Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
8 papers
Recent·Most cited
E. Ascic, F. Akerstrom, M. Sreekumar Nair, A. Rosa, I. Kurochkin, O. Zimmermannova, X. Catena, N. Rotankova, C. Veser, M. Rudnik, T. Ballocci, T. Scharer, X. Huang, M. de Rosa Torres, E. Renaud, , C.-F. Pereira
This study reprograms tumor cells in vivo to function as dendritic cells, leading to tumor regression and long-term immunity in mouse models.
bioRxiv · Jul 8, 2024 · PreprintImmunology
C. Deakin, G. Cornish, K. Ng, N. Faulkner, W. Bolland, V. Panova, J. Hope, A. Rosa, R. Harvey, S. Hussain, C. Earl, B. Jebson, M. Wilkinson, L. Marshall, K. O'Brien, , G. Kassiotis
The paper examines antibody responses to HCoV-OC43 and SARS-CoV-2 in children with autoimmune rheumatic diseases, finding stronger spike antibody responses and cross-reactivity despite immunosuppressive treatment.
bioRxiv · Feb 15, 2021 · PreprintImmunology
A. Alrubayyi, E. Gea-Mallorqui, E. Touizer, D. Hameiri-Bowen, J. Kopycinski, B. Charlton, N. Fisher-Pearson, L. Muir, A. Rosa, C. Roustan, C. Earl, P. Cherepanov, P. Pellegrino, L. Waters, F. Burns, , D. Peppa
This study examines SARS-CoV-2-specific immune responses in people living with HIV on ART, finding comparable antibody and T cell responses to HIV-negative individuals, with T cell magnitude linked to CD4 T cell pool size and CD4:CD8 ratio.
bioRxiv · Feb 15, 2021Immunology
C. Graham, J. Seow, I. Huettner, H. Khan, N. Kouphou, S. Acors, H. Winstone, S. Pickering, R. Pedro Galao, M. Jose Lista, J. M. Jimenez-Guardeno, A. G. Laing, Y. Wu, M. Joseph, L. Muir, , K. J. Doores
This study examines how mutations in the B.1.1.7 variant of SARS-CoV-2 affect neutralization by monoclonal antibodies targeting non-RBD epitopes.
bioRxiv · Feb 3, 2021 · PreprintImmunology
C. Rees-Spear, L. Muir, S. A. Griffith, J. Heaney, Y. Aldon, J. Snitselaar, P. Thomas, C. Graham, J. Seow, N. Lee, A. Rosa, C. Roustan, C. F. Houlihan, R. W. Sanders, R. K. Gupta, , L. E. McCoy
This study evaluates how Spike mutations in SARS-CoV-2 variants affect neutralization by monoclonal and polyclonal antibodies, showing reduced activity in some cases.
bioRxiv · Jan 15, 2021 · PreprintImmunology
K. W. Ng, N. Faulkner, G. Cornish, A. Rosa, R. Harvey, S. Hussain, R. Ulferts, C. Earl, A. Wrobel, D. Benton, C. Roustan, W. Bolland, R. Thompson, A. Agua-Doce, P. Hobson, , Mc
The paper identifies pre-existing and de novo humoral immunity to SARS-CoV-2 in humans, showing that uninfected individuals have SARS-CoV-2 S-reactive antibodies, particularly in children, and that infection leads to higher antibody titres targeting multiple subunits.
bioRxiv · May 14, 2020Immunology
G. M. Pugliese, F. Salaris, V. Palermo, V. Marabitti, N. Morina, A. Rosa, A. Franchitto, P. Pichierri
This study generates SMARCAL1 knock-down iPSCs to model Schimke immune-osseous dysplasia, revealing replication stress and altered gene expression as key factors in disease pathogenesis.
bioRxiv · Feb 10, 2019Cell Biology
I. Geudens, B. Coxam, S. Alt, V. Gebala, A.-C. Vion, A. Rosa, H. Gerhardt
The paper shows that zebrafish trunk vasculature balance is controlled by early genetic programming and flow-mediated adjustments.
bioRxiv · Aug 29, 2018 · PreprintCell Biology